{
    "SPADE_UN_26910": {
        "Sequence Information": {
            "Peptide Name": "LP1",
            "Sequence": "KKKKLKKILKKLFQFINQLDNQLQDIKQNK",
            "Sequence Length": 30,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer\n2. Immunomodulation",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities",
                    "Pubmed ID": "39116273",
                    "Reference": "J Med Chem. 2024;67:14040-14061",
                    "Author": "Deb R, Torres MDT, Boudný M, Koběrská M, Cappiello F, Popper M, Dvořáková Bendová K, Drabinová M, Hanáčková A, Jeannot K, Petřík M, Mangoni ML, Balíková Novotná G, Mráz M, de la Fuente-Nunez C, Vácha R",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39116273"
                }
            ],
            "Mass": 3712.48,
            "PI": 10.37,
            "Net Charge": 8,
            "Hydrophobicity": -1.2,
            "Frequent Amino Acids": "KLQ",
            "Absent Amino Acids": "ACEGHMOPRSTUVWY",
            "Basic Residues": 10,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 10,
            "Polar Residues": 20,
            "Positive Residues": 10,
            "Negative Residues": 2,
            "SPADE ID": "SPADE_UN_26910",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02379",
                    "Similarity": 1.0,
                    "Sequence": "WLGSALKIGAKLLPSVVGLFQKKKK"
                },
                {
                    "SPADE_ID": "SPADE_N_10082",
                    "Similarity": 1.0,
                    "Sequence": "GFGKGFGKKKKK"
                },
                {
                    "SPADE_ID": "SPADE_N_10083",
                    "Similarity": 1.0,
                    "Sequence": "GFGKGFGKKKKK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=>50 µM,Human umbilical cord-derived mesenchymal cells UC-MSC:IC50=2.0 µM,Human dermal fibroblasts:IC50=7.2 µM",
            "Target Organism": "Escherichia coli TOP 10(MIC=0.8µM),Staphylococcus carnosus CCM 4838T(MIC=0.8µM),Staphylococcus aureus NRS 1(MIC=>16µM),Klebsiella pneumoniae ATCC 700603(MIC=4µM),Acinetobacter baumannii GSAB 164(MIC=1µM),Pseudomonas aeruginosa NCTC 13437(MIC=>16µM),Escherichia coli ATCC 25922(MIC=1µM),Enterococcus faecalis JH-2-2(MIC=>32µM),Enterococcus faecalis UCN41(MIC=>32µM),Enterococcus faecium ATCC 19434(MIC=>32µM),Enterococcus faecium BM4147(MIC=16µM),Staphylococcus aureus ATCC 25923(MIC=>8µM),Acinetobacter baumannii CIP 7010(MIC=2µM),Enterococcus faecalis ATCC 700802(MIC=>60µM),Enterococcus faecium ATCC 700221(MIC=12.5µM),Staphylococcus aureus ATCC 12600(MIC=50µM),Staphylococcus aureus ATCC BAA-1556(MIC=>60µM),Klebsiella pneumoniae ATCC 13883(MIC=0.2µM),Acinetobacter baumannii ATCC 19606(MIC=0.8µM),Pseudomonas aeruginosa PAO1(MIC=3.1µM),Pseudomonas aeruginosa PA14(MIC=3.1µM),Escherichia coli ATCC 11775(MIC=1.6µM),Escherichia coli AIC221(MIC=0.8µM),Escherichia coli AIC222(MIC=1.6µM),Enterococcus faecium Z906(MIC=>32µM),Staphylococcus aureus ATCC 29213(MIC=>32µM),Klebsiella pneumoniae E1120(MIC=8µM),Klebsiella pneumoniae E1267(MIC=>32µM),Klebsiella pneumoniae 4371(MIC=16µM),Acinetobacter baumannii Z13(MIC=4µM),Pseudomonas aeruginosa K12(MIC=>32µM),Escherichia coli E1098(MIC=1µM),Human renal carcinoma A498(IC50=3.6µM),Human lung carcinoma A549(IC50=8.4µM),Human kidney carcinoma Caki-1(IC50=6.6µM),Human prostate cancer DU145(IC50=5.9µM),Human lung carcinoma NCI-H460(IC50=3.7µM),Human colon adenocarcinoma HCT 116(IC50=7.1µM),Human colon adenocarcinoma HCT-15(IC50=4.7µM),Human promyelocytic leukemia HL-60(IC50=6.5µM),Human myelogenous leukemia K562(IC50=6.4µM),Human breast adenocarcinoma MCF-7(IC50=8.3µM),Human breast adenocarcinoma MDA-MB-231(IC50=6.7µM),Human breast adenocarcinoma MDA-MB-435(IC50=1.4µM),Human lymphoblastic leukemia Molt-4(IC50=16µM),Human epithelial carcinoma OVCAR-3(IC50=4.9µM),Human prostate adenocarcinoma PC-3(IC50=16µM),Human Myeloma cells RPMI-8226(IC50=4.4µM),Human ovarian adenocarcinoma SK-OV-3(IC50=13µM),Human colon adenocarcinoma SW620(IC50=29µM),Human breast cancer T47D(IC50=3.2µM),Human glioblastoma U251-MG(IC50=20µM)"
        }
    }
}